CRI spoke with Ira Mellman, Ph.D., winner of the 2022 AACR-CRI Lloyd J. Old Award in Cancer Immunology. #AACR22 #Immunology
Ira Mellman, Ph.D. will receive the 2022 AACR-Cancer Research Institute (CRI) Lloyd J. Old Award in Cancer Immunology at the AACR Annual Meeting 2022 in New Orleans, April 8-13, 2022.
Mellman is the vice president of cancer immunology at Genentech and an adjunct professor at the University of California, San Francisco. He is being honored for his seminal contributions to characterizing dendritic cell function, and for applying these learnings to advance atezolizumab (Tecentriq) and neoepitope vaccines into the clinic.
The AACR-CRI Lloyd J. Old Award in Cancer Immunology recognizes an active scientist whose outstanding and innovative research has made a major impact on the cancer field and has the potential to stimulate new directions in cancer immunology.
About Ira Mellman:
[ Ссылка ]
About the Lloyd J. Old Award:
[ Ссылка ]
Award Release:
[ Ссылка ]
Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. [ Ссылка ]
Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.
![](https://s2.save4k.ru/pic/aq-e0pjY01A/maxresdefault.jpg)